# Safety,Efficacy and Pharmacokinetics Evaluation of SCT800 in Previously Treated Paediatric Patients With Severe Haemophilia A.

> **NCT03947320** · PHASE3 · UNKNOWN · sponsor: **Sinocelltech Ltd.** · enrollment: 70 (estimated)

## Conditions studied

- Hemophilia A

## Interventions

- **DRUG:** Recombinant Human Coagulation FVIII

## Key facts

- **NCT ID:** NCT03947320
- **Lead sponsor:** Sinocelltech Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-12-20
- **Primary completion:** 2020-09-20
- **Final completion:** 2020-09-20
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2019-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03947320

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03947320, "Safety,Efficacy and Pharmacokinetics Evaluation of SCT800 in Previously Treated Paediatric Patients With Severe Haemophilia A.". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03947320. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*